NCT04743609View on ClinicalTrials.gov

RSV Burden in Outpatient Settings

UnknownOBSERVATIONAL
Enrollment

3,500

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

January 11, 2024

Study Completion Date

January 11, 2024

Conditions
RSV InfectionChildren, OnlyOutpatientBronchiolitisOtitis MediaPneumonia
Interventions
DIAGNOSTIC_TEST

nasopharyngeal samples

rapid antigen test for Sars Cov-2, influenza and RSV. multiplex RT-PCR for a subgroup of 500 patients

Trial Locations (1)

94000

RECRUITING

ACTIV, Créteil

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Association Clinique Thérapeutique Infantile du val de Marne

OTHER